Veraxa and OmniAb to develop bispecific ADC tumour programme

finance.yahoo.com/news/veraxa-omniab-develop-bispecific-adc-140925847.html

In This Article:
Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) programme aimed at solid tumours.
The partnership unites OmniAb's transgenic antibody discovery solutions with Veraxa's ADC linker technology and…

This story appeared on finance.yahoo.com, 2025-05-06 14:09:25.
The Entire Business World on a Single Page. Free to Use →